Ophthalmomandibulomelic dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2741OMIM:164900Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ophthalmomandibulomelic dysplasia (OMMD), also known as pillay syndrome, is an extremely rare congenital disorder characterized by a triad of abnormalities affecting the eyes, jaw, and limbs. The condition was first described in 1964 and only a very small number of cases have been reported in the medical literature. The key clinical features include corneal opacities or other eye abnormalities (such as corneal clouding and temporalization of the inner canthi), hypoplasia or fusion abnormalities of the mandible (underdevelopment of the jawbone, sometimes with temporomandibular joint fusion leading to limited mouth opening), and limb defects predominantly affecting the upper extremities. Limb anomalies may include absent or hypoplastic radius, radioulnar synostosis, and other forearm malformations. These skeletal abnormalities can significantly impact hand and arm function. Due to the extreme rarity of this condition, there is no specific treatment. Management is supportive and symptomatic, typically involving a multidisciplinary team including ophthalmologists, orthopedic surgeons, oral and maxillofacial surgeons, and geneticists. Surgical interventions may be considered to address corneal opacities, improve jaw mobility, or correct limb deformities. The underlying genetic cause has not been definitively established, and the inheritance pattern remains uncertain, though autosomal dominant transmission has been suggested in some reported families.

Also known as:

Clinical phenotype terms— hover any for plain English:

MegalocorneaHP:0000485MesomeliaHP:0003027Abnormality of bone mineral densityHP:0004348Obtuse angle of mandibleHP:0005446Ulnar deviated club handsHP:0006055Radioulnar dislocationHP:0006439Lateral humeral condyle aplasiaHP:0006441Temporomandibular joint ankylosisHP:0012478
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ophthalmomandibulomelic dysplasia.

View clinical trials →

No actively recruiting trials found for Ophthalmomandibulomelic dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ophthalmomandibulomelic dysplasia community →

No specialists are currently listed for Ophthalmomandibulomelic dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ophthalmomandibulomelic dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ophthalmomandibulomelic dysplasiaForum →

No community posts yet. Be the first to share your experience with Ophthalmomandibulomelic dysplasia.

Start the conversation →

Latest news about Ophthalmomandibulomelic dysplasia

No recent news articles for Ophthalmomandibulomelic dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ophthalmomandibulomelic dysplasia

What is Ophthalmomandibulomelic dysplasia?

Ophthalmomandibulomelic dysplasia (OMMD), also known as pillay syndrome, is an extremely rare congenital disorder characterized by a triad of abnormalities affecting the eyes, jaw, and limbs. The condition was first described in 1964 and only a very small number of cases have been reported in the medical literature. The key clinical features include corneal opacities or other eye abnormalities (such as corneal clouding and temporalization of the inner canthi), hypoplasia or fusion abnormalities of the mandible (underdevelopment of the jawbone, sometimes with temporomandibular joint fusion lea

How is Ophthalmomandibulomelic dysplasia inherited?

Ophthalmomandibulomelic dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Ophthalmomandibulomelic dysplasia typically begin?

Typical onset of Ophthalmomandibulomelic dysplasia is neonatal. Age of onset can vary across affected individuals.